Hints and tips:
Related Special Reports
Related Topics
...The New York-based pharma group has acquired four companies — Arena, ReViral, Biohaven and Global Blood Therapeutics — that it expects will contribute about $10bn in revenues in 2030....
...Astellas Pharma bought eye-treatment specialist Iveric Bio in a $5.9bn deal in May. Mizuho splashed out $550mn for US boutique investment bank Greenhill & Co....
Company would have been better off following Roche’s route to market for anti-obesity treatment
...Astellas Pharma has agreed to buy US biotech group Iveric Bio for roughly $5.9bn, marking the Japanese drugmaker’s largest-ever acquisition and giving it access to the rapidly expanding market for age-related...
...It remained unclear whether the arrest was politically motivated or specific to Astellas....
...Japan has said 17 of its citizens have been detained since China passed a counter-espionage law in 2014, of whom five remain in detention, including an executive of Astellas Pharma who was taken into custody...
...Biotech business Redx Pharma this week blamed low liquidity on London’s junior market for its decision to delist its shares from Aim and re-register as a private company....
...But some investors believe selling discipline against a shot is a losing game when big pharma companies are competing to meet the demands of the one in eight people worldwide who are classed as obese....
...The antitrust challenge may force big pharma groups to rethink “pure play” business models. The Lex team is interested in hearing more from readers. Is the FTC right to challenge pharma deals?...
Swiss pharma group acquires rights to develop and manufacture bowel disease treatment
...Earlier this month, Johnson & Johnson and Japanese drugmaker Astellas Pharma filed lawsuits against the Biden administration’s reforms, following on from legal challenges filed by Merck, Bristol Myers Squibb...
...The first three sources are not the exclusive realm of knowledge industries such as tech or pharma....
...But pressure is mounting on pharma companies to switch to synthetic substances as populations decline for horseshoe crabs and seabirds that eat the creatures’ eggs....
...Horizon had also attracted interest from French drugmaker Sanofi and US pharma group Johnson & Johnson....
...Some pharma companies disputed the annual cost figures published by the health department....
...Merck’s research chief has called on the UK government to make the country more welcoming to pharma companies, ahead of the US-based drugmaker breaking ground on a £1bn research centre in London next week...
...Big Pharma has always bought out small drug developers to restock its pipelines. Some emerging health science companies aspire to be the next Amgen, which has a market capitalisation of $120bn....
...Pao, speaking at the Financial Times US Pharma and Biotech Summit in New York, said he was confident the FTC would approve the Seagen deal....
US regulator sues to block takeover of biotech group Horizon Therapeutics
...Regulators have taken notice after a study sparked fresh doubts over the usefulness of a Covid drug made by US pharma group Merck, raising questions about the costly procurement of antivirals during the...
...In a quieter deal environment, this deal underscores that Big Pharma has the means to make big bets....
...Pharma group and hit London-headquartered Deloitte with a record fine....
...Pharma on espionage charges....
...It has also raided US due diligence firm Mintz and Bain, the consultancy, and detained an executive from Japan’s Astellas Pharma group....
...If you have the long pharma/short junk food pair trade on, email us: robert.armstrong@ft.com and ethan.wu@ft.com....
International Edition